Cynthia de Luise, PhD, MPH

Senior Director, Safety Surveillance Research
Pfizer Pharmaceuticals

Poster(s):

• (A-339) 2024 interim results from the VAC4EU post-authorisation safety study (PASS) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) in Europe
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-093) Preliminary results from a European post authorization study to assess the safety of Paxlovid among patients with moderate or severe hepatic or renal impairment
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-257) Preliminary Results from a European Post-Authorization Study to Assess the Safety of Paxlovid in Pregnancy
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET